T

Tamovac I

A Phase I/II trial to assess safety and immunogenicity of intradermal (ID) DNA priming, intramuscular (IM) MVA and IM rgp140/GLA-AF boosting in healthy volunteers in Tanzania and to develop further HIV vaccine trial capacity building in Tanzania.

TaMoVac II

HIV vaccine trial capacity building in Tanzania and Mozambique by continued exploration of optimal DNA priming and MVA boosting strategies

TAPS

Transfusion Alternatives Pre-operatively in Sickle-cell disease (TAPS) randomised controlled trial

TB-CHAMP

Tuberculosis Child Multidrug-resistant Preventive Therapy Trial

TE04

A prospective study of surveillance in stage 1 non-seminomatous testicular tumours

TE05

Adjuvant bleomycin, etoposide and cisplatin (BEP) in the treatment of "high risk" stage I non-seminomatous germ cell tumours

TE08

A randomised trial of two vs five CT scans in the surveillance of patients with stage I non-seminomatous germ cell tumours of the testis

TE09

Randomised trial of carboplatin- vs cisplatin based chemotherapy for good prognosis metastatic non-seminomatous germ cell tumours

TE11

A prospective study of risk factors for carcinoma in situ of the contralateral testis in patients with testicular cancer

TE12

A randomised trial of single agent carboplatin vs etoposide and cisplatin for advanced metastatic seminoma

TE13

A randomised trial of BEP (bleomycin, etoposide, cisplatin) vs BOP/VIP-B (bleomycin, vincristine, cisplatin, etoposide, ifosfamide cisplatin, bleomycin) and of the same regimens with or without G-CSF in poor prognosis metastatic germ cell tumours

TE14

Prognostic factors for patients with advanced seminoma treated with platinum based chemotherapy

TE15

Prognostic factors in patients progressing after platinum-based chemotherapy for metastatic non-seminomatous germ cell tumours

TE16

Post chemotherapy residual masses in germ cell tumour patients

TE17

Adjuvant bleomycin, vincristine and cisplatin for high-risk stage I non-seminomatous germ cell tumours

TE20

A randomised trial of 3 cycles of BEP versus 3 cycles of BEP plus 1 cycle of EP and the 3-day versus the 5-day schedule in good prognosis metastatic germ cell cancer

TE21 (EORTC 30983)

A randomised trial of BEP vs Taxol-BEP in histologically proven metastatic germ cell cancer with intermediate prognosis

TE23

A randomised phase II trial of intensive induction chemotherapy (CBOP/B15EP) and standard BEP chemotherapy in poor prognosis male germ cell tumours

TIME1

The first therapeutic intervention in malignant pleural effusion trial

TIME2

The second therapeutic intervention in malignant effusion trial

TIME3

A randomised controlled trial to evaluate whether use of intrapleural urokinase aids the drainage of multi-septated malignant pleural effusion compared to placebo

TOPPS

A Randomised Controlled Trial Of Prophylactic Vs No-Prophylactic Platelet transfusions in Patients with Haematological malignancies

TRACT

Transfusion and Treatment of severe Anaemia in African Children: a randomised controlled Trial

TRANSORCE

A study to collect blood and tissue samples from consenting patients who have been diagnosed with kidney cancer

TRISST (MRC TE24)

Trial of imaging and schedule in seminoma testis

TRUNCATE-TB

Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for drug-sensitive Tuberculosis

Top-Up

Microbicides Development Programme Top-Up study